ClinVar Miner

Submissions for variant NM_001244008.2(KIF1A):c.3668C>T (p.Thr1223Met)

gnomAD frequency: 0.00021  dbSNP: rs374873057
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 11
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000190656 SCV000244096 uncertain significance Inborn genetic diseases 2019-09-29 criteria provided, single submitter clinical testing The p.T1122M variant (also known as c.3365C>T), located in coding exon 32 of the KIF1A gene, results from a C to T substitution at nucleotide position 3365. The threonine at codon 1122 is replaced by methionine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Illumina Laboratory Services, Illumina RCV000311119 SCV000429235 uncertain significance Spastic Paraplegia, Recessive 2016-06-14 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000356396 SCV000429236 uncertain significance Hereditary sensory and autonomic neuropathy type 2 2016-06-14 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000401309 SCV000429237 uncertain significance Intellectual Disability, Dominant 2016-06-14 criteria provided, single submitter clinical testing
Genetic Services Laboratory, University of Chicago RCV000504400 SCV000595401 uncertain significance not specified 2016-08-26 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV000639825 SCV000761406 likely benign Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory, type 2C; Intellectual disability, autosomal dominant 9 2024-01-24 criteria provided, single submitter clinical testing
GeneDx RCV001545198 SCV001764479 uncertain significance not provided 2024-10-01 criteria provided, single submitter clinical testing Reported previously, using alternate nomenclature, in a patient with HSP; however, no further clinical or segregation information was provided (PMID: 29691679); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 29691679)
Genome Diagnostics Laboratory, The Hospital for Sick Children RCV001847846 SCV002104864 uncertain significance Hereditary spastic paraplegia 2020-05-01 criteria provided, single submitter clinical testing
Athena Diagnostics RCV001545198 SCV002770539 uncertain significance not provided 2022-03-18 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000504400 SCV004028880 uncertain significance not specified 2023-07-06 criteria provided, single submitter clinical testing Variant summary: KIF1A c.3365C>T (p.Thr1122Met) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00022 in 205930 control chromosomes in the gnomAD database, including 1 homozygotes. c.3365C>T has been reported in the literature in an individual affected with Hereditary Spastic Paraplegia and the variant was inherited from an asymptomatic parent (example: Travaglini_2018). This report does not provide unequivocal conclusions about association of the variant with NESCAV Syndrome. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 29691679). Eight submitters have cited clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as likely benign (n=1) and VUS (n=7). Based on the evidence outlined above, the variant was classified as uncertain significance.
Centre de Biologie Pathologie Génétique, Centre Hospitalier Universitaire de Lille RCV001252530 SCV001428287 uncertain significance Intellectual disability 2019-01-01 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.